Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical . . . ASPEN-1 was a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy, duration of response, and safety of 2 doses of DaxibotulinumtoxinA for Injection (DAXI), a novel botulinum toxin type A formulation in participants with cervical dystonia (CD)
Efficacy and safety of botulinum type A toxin (Dysport) in cervical . . . Botulinum toxin type A (Dysport) has been shown in European studies to be a safe and effective treatment for cervical dystonia This multicenter, double-blind, randomized, controlled trial assessed the safety and efficacy of Dysport in cervical dystonia patients in the United States
Long-term efficacy and safety of botulinum toxin type A (Dysport) in . . . The aim of this study was to evaluate the efficacy and safety of intramuscular (IM) administration of botulinum toxin type A (Dysport ®, Ipsen Biopharm Ltd ) for the treatment of cervical dystonia (CD) and the long-term safety and efficacy of repeated treatments
Botulinum Toxin in the Treatment of Cervical Dystonia: Evidence-Based . . . Several studies, including nearly two dozen randomized clinical trials, have shown that botulinum toxin is safe and effective in reducing the clinical severity of cervical dystonia Longitudinal data have demonstrated decades of sustained benefit and safety
Efficacy and safety of botulinum type A toxin (Dysport) in cervical . . . Botulinum toxin type A (Dysport) has been shown in European studies to be a safe and effective treatment for cervical dystonia This multicenter, double‐blind, randomized, controlled trial assessed the safety and efficacy of Dysport in cervical dystonia patients in the United States
Checking your browser - reCAPTCHA - PubMed Checking your browser before accessing pubmed ncbi nlm nih gov Click here if you are not automatically redirected after 5 seconds
Long-Term Efficacy and Safety of Botulinum Toxin Injections in Dystonia A randomized, multicenter, double-blind study evaluated the efficacy of OnabotulinumtoxinA versus placebo for the treatment of cervical dystonia The impact of the subjects’ neutralizing antibody status at study entry on clinical response was analyzed
Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN The objective of this study was to compare the safety and efficacy of incobotulinumtoxinA (120U, 240U; Merz Pharmaceuticals) to placebo in subjects with cervical dystonia (CD)